Skip to main content

Bank Julius Baer & Co. Ltd, Zurich

Bank

Position in NBIX — Neurocrine Biosciences Inc

CIK 1544599 ZURICH, V8

Position in NBIX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$4,007,881
+$2,740,806 QoQ
Shares Held
23,780
+147.2% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#237
of 768 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Bank Julius Baer & Co. Ltd, Zurich holds $50,041,551 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (8.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
23,780 $4,007,881

All Filings in NBIX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,007,881 23,780
2026-03-31 $1,267,075 9,618
2025-12-31 $1,689,620 11,913
2023-12-31 $142,827 1,084
2023-09-30 $123,412 1,097
2022-12-31 $295,494 2,474
2022-09-30 $178,432 1,680
2022-03-31 $14,062 150